Related references
Note: Only part of the references are listed.Combinatorial Library Enumeration and Lead Hopping using Comparative Interaction Fingerprint Analysis and Classical 2D QSAR Methods for Seeking Novel GABAA α3 Modulators
R. S. K. Vijayan et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
New Hybrid Genetic Based Support Vector Regression as QSAR Approach for Analyzing Flavonoids-GABA(A) Complexes
Mohammad Goodarzi et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
QSAR modeling of the interaction of flavonoids with GABA(A) receptor
Pablo R. Duchowicz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity MUSCARINIC PARTIAL AGONIST McN-A-343 AS A BITOPIC ORTHOSTERIC/ALLOSTERIC LIGAND
Celine Valant et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Selective influence on contextual memory:: Physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the α5 subunit
Danni Harris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Structural basis for ligand recognition at the benzodiazepine binding site of GABAA α3 receptor, and pharmacophore-based virtual screening approach
R. S. K. Vijayan et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2008)
Molecular modelling of the GABAA ion channel protein
Valerie Campagna-Slater et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2007)
An updated unified pharmacophore model of the benzodiazepine binding site on gamma-aminobutyric Acid(a) receptors: Correlation with comparative models
T. Clayton et al.
CURRENT MEDICINAL CHEMISTRY (2007)
4-quinolone derivatives:: High-affinity ligands at the benzodiazepine site of brain GABAA receptors. synthesis, pharmacology, and pharmacophore modeling
E Lager et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Imidazo[1,2-a]pyrazin-8-ones, imidazo[1,2-d][1,2,4]triazin-8-ones and imidazo[2,1-f][1,2,4]triazin-8-ones as α2/α3 subtype selective GABAA agonists for the treatment of anxiety
SC Goodacre et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Potent 4-arylalkyl-substituted 3-isothiazolol GABAA competitive/noncompetitive antagonists:: Synthesis and pharmacology
D Krehan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Discovery of imidazo[1,2-b][1,2,4]triazines as GABAA α2/3 subtype selective agonists for the treatment of anxiety
MGN Russell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Charged residues in the α1 and β2 pre-M1 regions involved in GABAA receptor activation
J Mercado et al.
JOURNAL OF NEUROSCIENCE (2006)
Imidazo[1,2-a]pyrimidines as functionally selective and orally bioavailable GABA-α2/α3 binding site agonists for the treatment of anxiety disorders
SC Goodacre et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine:: A functionally selective γ-aminobutyric acidA (GABAA) α2/α3-subtype selective agonist that exhibits potent anxiolytic activity but is not sedating in animal models
RW Carling et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Comparative models of GABAA receptor extracellular and transmembrane domains:: Important insights in pharmacology and function
M Ernst et al.
MOLECULAR PHARMACOLOGY (2005)
Homology model of the GABAA receptor examined using Brownian dynamics
M O'Mara et al.
BIOPHYSICAL JOURNAL (2005)
Discovery of functionally selective 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABAA receptor agonists at the α3 subunit
MGN Russell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Pseudoreceptor models and 3D-QSAR for imidazobenzodiazepines at GABAA/BzR subtypes αxβ3γ2 [x=1-3, 5, and 6] via flexible atom receptor model
AJ Lu et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2004)
3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-α]phthalazines and analogues:: High-affinity γ-aminobutyric acid-A benzodiazepine receptor ligands with α2, α3, and α5-subtype binding selectivity over α1
RW Carling et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
An arginine involved in GABA binding and unbinding but not gating of the GABAA receptor
DA Wagner et al.
JOURNAL OF NEUROSCIENCE (2004)
The use of a pharmacophore model for identification of novel ligands for the benzodiazepine binding site of the GABAA receptor
P Kahnberg et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2004)
The Cys-loop superfamily of ligand-gated ion channels: the impact of receptor structure on function
CN Connolly et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2004)
The GABAA receptor α1 subunit Pro174-Asp191 segment is involved in GABA binding and channel gating
JG Newell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
3D-pharmacophores of flavonoid binding at the benzodiazepine GABA(A) receptor site using 4D-QSAR analysis
X Hong et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2003)
Refinement and evaluation of a pharmacophore model for flavone derivatives binding to the benzodiazepine site of the GABAA receptor
P Kahnberg et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Molecular and pharmacological characterization of GABAA receptor α1 subunit knockout mice
JE Kralic et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Contribution of the α1-GABAA receptor subtype to the pharmacological actions of benzodiazepine site inverse agonists
F Crestani et al.
NEUROPHARMACOLOGY (2002)
Novel class of potent 4-arylalkyl substituted 3-isoxazolol GABAA antagonists:: Synthesis, pharmacology, and molecular modeling
B Frolund et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Drug interactions at GABAA receptors
ER Korpi et al.
PROGRESS IN NEUROBIOLOGY (2002)
GABAA receptor β2 Tyr97 and Leu99 line the GABA-binding site -: Insights into mechanisms of agonist and antagonist actions
AJ Boileau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
3D-QSAR model of flavonoids binding at benzodiazepine site in GABAA receptors
XQ Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Development and assessment of a 3D pharmacophore for ligand recognition of BDZR/GABAA receptors initiating the anxiolytic response
DL Harris et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2000)
Molecular and neuronal substrate for the selective attenuation of anxiety
K Löw et al.
SCIENCE (2000)
Pharmacophore/receptor models for GABAA/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a comprehensive ligand-mapping approach
Q Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
